Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Parkinson Disease, Secondary (pathology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease, Secondary (mortality) < Parkinson Disease, Secondary (pathology) < Parkinson Disease, Secondary (physiopathology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
000010 (1999) R H Walker [États-Unis] ; H. Spiera ; M F Brin ; C W OlanowParkinsonism associated with Sjögren's syndrome: three cases and a review of the literature.
000026 (1999) E. Marchioni [Italie] ; D. Soragna ; M. Versino ; L. Sibilla ; E. Alfonsi ; A. Romani ; R. Manni ; F. SavoldiHemiparkinsonism-hemiatrophy with brain hemihypoplasia.
000027 (1999) G. Cicarelli [Italie] ; M T Pellecchia ; F. Maiuri ; P. BaroneBrain stem cystic astrocytoma presenting with "pure" parkinsonism.
000268 (2000) D A Di Monte [États-Unis] ; A. Mccormack ; G. Petzinger ; A M Janson ; M. Quik ; W J LangstonRelationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
000279 (2000) I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. TisonToward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
000522 (2001) C. Marras [Canada] ; A E Lang ; L C Ang ; J. Zijlmans ; G K Wenning69-year-old man with gait disturbance and Parkinsonism.
000524 (2001) E R Barbosa [Brésil] ; M D Leiros Da Costa ; L A Bacheschi ; M. Scaff ; C C LeiteParkinsonism after glycine-derivate exposure.
000802 (2002) Y. Kim [Corée du Sud] ; J-M Kim ; J-W Kim ; C-I Yoo ; C R Lee ; J H Lee ; H K Kim ; S O Yang ; H K Chung ; D S Lee ; B. JeonDopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
000D10 (1992) V M De Bruin [Royaume-Uni] ; A J Lees ; S E DanielDiffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report.
000D15 (1992) P. Vieregge ; W. Klostermann ; H. BrückmannParkinsonism in multiple sclerosis.
000D18 (1992) N. Giladi ; S. FahnHemiparkinsonism-hemiatrophy syndrome may mimic early-stage cortical-basal ganglionic degeneration.
001859 (2006) Annu Aggarwal [Inde] ; Sachin Vaidya ; Samir Shah ; Joshita Singh ; Shrinivas Desai ; Mohit BhattReversible Parkinsonism and T1W pallidal hyperintensities in acute liver failure.
001C00 (2007) Jan Zijlmans [Royaume-Uni] ; Andrew Evans ; Flavia Fontes ; Regina Katzenschlager ; Svetoslav Gacinovic ; Andrew J. Lees ; Durval Costa[123I] FP-CIT spect study in vascular parkinsonism and Parkinson's disease.
002610 (2009) Natasha Mevawalla ; Victor Fung ; John Morris ; Glenda Margaret HallidayUnilateral rest tremor in vascular parkinsonism associated with a contralateral lesion of the locus coeruleus.
004167 (1989) L I Golbe ; D C Miller ; R C DuvoisinParaneoplastic degeneration of the substantia nigra with dystonia and parkinsonism.
004563 (1987) F. Grandas [Royaume-Uni] ; N. Quinn ; P. Critchley ; A. Rohan ; C D Marsden ; S M StahlAntiparkinsonian activity of a single oral dose of PHNO.
004831 (1994) T U Hoogenraad ; G H JansenAlzheimer type II cells in multiple system atrophy?
004834 (1994) T. Curran [Canada] ; A E LangParkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses.
004856 (1994) R K Mosewich [Canada] ; A H Rajput ; A. Shuaib ; B. Rozdilsky ; L. AngPulmonary embolism: an under-recognized yet frequent cause of death in parkinsonism.
004967 (1993) K. Bhatia [Royaume-Uni] ; S E Daniel ; C D MarsdenOrofacial dystonia and rest tremor in a patient with normal brain pathology.
004A08 (1993) B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P J BédardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease, Secondary (pathology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease, Secondary (pathology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease, Secondary (pathology)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024